MATR News: RxElite receives $5MM funding from NPIL Pharma

"The State with the Best Education Wins!"

Read more stories about
Idaho Business>>

MATR Sponsor:

INL-Through collaboration with industry partners, INL's Technology Transfer and Commercialization office makes available to American agencies and international organizations unique facilities and expertise. Visit >>

MATR Supporters:

Magnificent Montana – Finding premier ranch, timber, agricultural, RENEWABLE ENERGY, GREEN and residential properties for the stewards of Montana’s lands and way of life. Visit >>

Highway 12 Ventures is an early-stage VC fund investing in high-growth, entrepreneurial companies in Idaho and the contiguous Intermountain West states of Oregon, Washington, Montana, and Utah. Visit >>

RxElite receives $5MM funding from NPIL Pharma

June 12, 2008

View for printing

RxElite, Inc. http://www.rxelite.com/ last week said it received financing from NPIL Pharma Inc.

Meridian-based RxElite develops, manufactures and markets specialty generic prescription drugs. The company said in a release that it entered an agreement with NPIL Pharma to fund up to $5 million through a secured, subordinated debt agreement. NPIL advanced $3 million of the total to RxElite at the conclusion of the transaction.

Full Story: http://www.idahobusiness.net/archive ... NPIL-Pharma
No reader comments so far. Be the first to comment by clicking the button below.

Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

E-mail this page to a friend!

Lijit Search